PhRMA sues Trump administration over Medicare GLOBE price pilot

PhRMA filed a lawsuit in the U.S. District Court for the District of Columbia challenging the Trump administration's GLOBE pilot that would tie Medicare Part B drug prices to those in peer nations.

The trade group says the most-favored nation approach exceeds Medicare's statutory authority.

The administration has exempted most companies, leaving only a handful subject to the pilot in exchange for voluntary agreements to charge Medicaid MFN prices, which limits the program's impact.

The case underscores the ongoing tension between the pharmaceutical industry and policymakers over efforts to lower drug costs in federal programs.